Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05059158

Amyloid-β Clearance Mechanisms in Alzheimer's Disease

Sponsor: Ludwig-Maximilians - University of Munich

View on ClinicalTrials.gov

Summary

The focus of this study is to examine the protein-plaque clearance (Aß) in relation to the blood-brain-barrier, the glymphatic system, brain lymphatic system and enzymatic degradation. In order to achieve this aim the investigators intend to study participants with a Subjective Cognitive Decline, Mild Cognitive Impairment and a mild Alzheimer's disease.

Official title: Amyloid-β Clearance Mechanisms: A Multi-modal Study on Lymphatic, Glymphatic and Blood-brain-barrier Function in Alzheimer's Disease

Key Details

Gender

All

Age Range

50 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

60

Start Date

2021-06-01

Completion Date

2025-10

Last Updated

2025-07-04

Healthy Volunteers

No

Interventions

RADIATION

positron emission tomography (PET)

18-Flutemetamol PET (clinical indicated) is going to be performed at the visit.

Locations (1)

Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums

München, Bavaria, Germany